) was measured by means of fluorescence analysis using pyrene as the fluorescent probe. The obtained micelles were characterized by DLS and AFM analysis and the ability to release the loaded doxorubicin was studied in different media. Finally the cytotoxicity profile on both cancer (HCT116) and normal (16 HBE) cell lines and in vitro ability to deliver the drug into cancer cells were evaluated.
No takes yet. Share an insight, caveat, or question.
Licciardi et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: